跳至主要内容
临床试验/NCT03717714
NCT03717714已完成不适用

A Randomized, Double-blind, Active Controlled, 12-week Follow-up, Pilot Study to Evaluate the Safety and Efficacy of Polycan in Combination With Glucosamine for Treatment of Knee Osteoarthritis

Vietstar Biomedical Research1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2017年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
1
主要终点
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) changes at 12 weeks in the three groups

研究概览

简要总结

The objectives of this study is to examine the Safety and Efficacy of black yeast beta-glucan produced from Aureobusidium pulluluns SM-2001 (Polycan), in combination with glucosamine in reducing knee osteoarthritis (OA) associated symptoms. This study is a double-blind, randomized, active-controlled trial conducted with 100 OA patients, aged 35-80 years using a formulated product

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of knee osteoarthritis (OA)
  • OA ranging from grade 1 to grade 3 by Kellgren and Lawrence system
  • Agree to participate into the study

排除标准

  • OA ranging from grade 4 by Kellgren and Lawrence system
  • Allergic or contradicted with oral NSAIDs (Meloxicam)
  • Pregnant and breastfeeding women.

研究组 & 干预措施

Glucosamine 1500mg

Active Comparator

Glucosamine 1500 mg per day for 12 weeks

干预措施: Glucosamine 1500 mg (Dietary Supplement)

Polycan & Glucosamine 750mg

Experimental

Polycan 50 mg + Glucosamine 750 mg per day for 12 weeks

干预措施: Polycan 50mg + Glucosamine 750 mg (Dietary Supplement)

Polycan & Glucosamine 1500mg

Experimental

Polycan 50 mg + Glucosamine 1500 mg per day

干预措施: Polycan 50mg + Glucosamine 1500 mg (Dietary Supplement)

结局指标

主要结局

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) changes at 12 weeks in the three groups

时间窗: Baseline to Week 12

The WOMAC consists of 24 items divided into 3 subscales: Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing Stiffness (2 items): after first waking and later in the day Physical Function (17 items): stair use, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy household duties, light household duties. Total WOMAC score ranges from 0 to 96 with higher scores indicate worse pain, stiffness, and functional limitations

次要结局

  • Number of dose of rescue medication (Meloxicam 7.5mg) used in the three groups.(Through study completion, an average of 12 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验